I-Corps: Novel File Exchange Software Platform to Increase Patient Volume and Hospital System Efficiency
I-Corps:新型文件交换软件平台,可增加患者数量和医院系统效率
基本信息
- 批准号:2204754
- 负责人:
- 金额:$ 5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2023-09-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The broader impact/commercial potential of this I-Corps project is the development of referral processing software to increase hospital system workflow efficiency without compromising patient volume. New patient appointments are important healthcare performance metrics because they are a significant revenue source and critical for strategic growth for all healthcare systems. The referral market is estimated at 2.3 billion dollars annually. In the United States, 1 out of 3 patients are referred to see a specialist every year. However, as many as 50% of these patient referrals are never completed – resulting in an estimated annual loss of $370 billion in revenue. This I-Corps project is based on the development of a software platform to process patient referrals to provide a more transparent closed-loop solution towards exchanging medical documents between two different hospital systems. The proposed technology employs machine learning algorithms to provide data analytics and insight into operational efficiency for hospital leadership. In addition, this information may be used to provide practice and behavioral recommendations to meet performance metrics defined by the institution. In doing so, the proposed technology addresses the major contributor to new patient scheduling delays and increases revenue for healthcare systems. It also may decrease delays in patient care and avoid repeating unneeded procedures and tests because of incomplete medical records.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
该 I-Corps 项目更广泛的影响/商业潜力是开发转诊处理软件,以在不影响患者数量的情况下提高医院系统工作流程效率。新患者预约是重要的医疗保健绩效指标,因为它们是重要的收入来源,对战略增长至关重要。在美国,每年有三分之一的患者被转诊去看专科医生,但其中多达 50% 的患者从未完成转诊。导致估计该 I-Corps 项目基于开发一个处理患者转诊的软件平台,为两个不同医院系统之间交换医疗文档提供更透明的闭环解决方案。此外,该信息可用于提供实践和行为建议,以满足机构定义的绩效指标。新患者的安排延迟并增加了医疗保健收入它还可以减少患者护理的延误,并避免因医疗记录不完整而重复不必要的程序和测试。该奖项反映了 NSF 的法定使命,并通过使用基金会的智力价值和更广泛的影响审查标准进行评估,被认为值得支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nicole Jiam其他文献
Nicole Jiam的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
- 批准号:82304658
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
- 批准号:82070530
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Continuous development of nTracer2 and its deployment at NIH image repositories
nTracer2 的持续开发及其在 NIH 图像存储库中的部署
- 批准号:
10726178 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Novel bioinformatics methods for integrative detection of structural variants from long-read sequencing
用于从长读长测序中综合检测结构变异的新型生物信息学方法
- 批准号:
10752265 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别: